China Expands AI-Controlled Labs to Automate Scientific Research
China is deploying autonomous AI-controlled laboratories to accelerate drug discovery and industrial research to compete with the United States.
The Government of China is expanding the use of AI-controlled laboratories to automate scientific research and strengthen national industrial capabilities. This strategic shift aims to increase the speed of innovation and enhance the country's ability to compete with the United States.
In Shenzhen, the drug-discovery firm XtalPi operates an autonomous facility where AI models independently devise hypotheses and direct robotic limbs to conduct experiments. These systems record results without significant human involvement, streamlining the research process.
Prime Minister Li Qiang characterized this move toward AI-driven automation as "the key to winning the future," signaling that the state views autonomous research as a critical component of its long-term economic and technological strategy.
